BDBM42450 (4E)-4-[4-(1,3-benzothiazol-2-yl)-1,2-dihydropyrazol-3-ylidene]-3-hydroxy-1-cyclohexa-2,5-dienone::(4E)-4-[4-(1,3-benzothiazol-2-yl)-1,2-dihydropyrazol-3-ylidene]-3-hydroxycyclohexa-2,5-dien-1-one::(4E)-4-[4-(1,3-benzothiazol-2-yl)-1,2-dihydropyrazol-3-ylidene]-3-oxidanyl-cyclohexa-2,5-dien-1-one::(4E)-4-[4-(1,3-benzothiazol-2-yl)-3-pyrazolin-3-ylidene]-3-hydroxy-cyclohexa-2,5-dien-1-one::MLS000680157::SMR000324423::US8754233, 4-(4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-benzene-1,3-diol::cid_6710438

SMILES Oc1ccc(-c2n[nH]cc2-c2nc3ccccc3s2)c(O)c1

InChI Key InChIKey=KUEDPQPSINBLKI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 42450   

TargetIntegrin-linked protein kinase(Human)
Dermira (Canada)

US Patent
LigandChemical structure of BindingDB Monomer ID 42450BDBM42450((4E)-4-[4-(1,3-benzothiazol-2-yl)-1,2-dihydropyraz...)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2014
Entry Details
US Patent